{
  "patient_id": "sigir-20141",
  "rank_folder": "rank1_NCT00133328",
  "trial_info": {
    "trial_id": "NCT00133328",
    "title": "A Morbidity-Mortality and Remodeling Study With Valsartan",
    "brief_summary": "The JIKEI HEART Study has been designed to investigate whether concomitant treatment with valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment, will improve the prognosis of 3000 Japanese patients with cardiovascular diseases.",
    "phase": "Phase 4",
    "drugs": [
      "valsartan"
    ],
    "diseases": [
      "Hypertension",
      "Ischemic Heart Disease",
      "Congestive Heart Failure"
    ],
    "enrollment": "3000.0"
  },
  "inclusion_criteria": [
    "patient_has_diagnosis_of_hypertensive_disorder_now",
    "patient_has_diagnosis_of_ischemic_heart_disease_now"
  ],
  "exclusion_criteria": [
    "patient_is_pregnant_now",
    "patient_has_finding_of_liver_damage_now",
    "patient_has_diagnosis_of_acute_myocardial_infarction_now"
  ]
}